Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
出版年份 2020 全文链接
标题
Application of Mycobacterium smegmatis as a surrogate to evaluate drug leads against Mycobacterium tuberculosis
作者
关键词
-
出版物
JOURNAL OF ANTIBIOTICS
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-05-29
DOI
10.1038/s41429-020-0320-7
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate
- (2019) Katsuhiko Mitachi et al. ORGANIC LETTERS
- Structure-based drug discovery by targeting N-glycan biosynthesis, dolichyl-phosphate N-acetylglucosaminephosphotransferase
- (2019) Michio Kurosu Future Medicinal Chemistry
- Drug Resistance Characteristics of Mycobacterium tuberculosis Isolates From Patients With Tuberculosis to 12 Antituberculous Drugs in China
- (2019) Xiaocui Wu et al. Frontiers in Cellular and Infection Microbiology
- Substrate Tolerance of Bacterial Glycosyltransferase MurG: Novel Fluorescence-Based Assays
- (2019) Katsuhiko Mitachi et al. ACS Infectious Diseases
- Structural absorption by barbule microstructures of super black bird of paradise feathers
- (2018) Dakota E. McCoy et al. Nature Communications
- An antimycobacterial pleuromutilin analogue effective against dormant bacilli
- (2018) Maddie R. Lemieux et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dormant Mycobacterium tuberculosis converts isoniazid to the active drug in a Wayne’s model of dormancy
- (2018) Sajith Raghunandanan et al. JOURNAL OF ANTIBIOTICS
- Fluorescence-based assay for polyprenyl phosphate-GlcNAc-1-phosphate transferase (WecA) and identification of novel antimycobacterial WecA inhibitors
- (2016) Katsuhiko Mitachi et al. ANALYTICAL BIOCHEMISTRY
- Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH
- (2016) Angelo Iacobino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Tuberculosis therapy for 2016 and beyond
- (2016) Michael Lauzardo et al. EXPERT OPINION ON PHARMACOTHERAPY
- Stereocontrolled Total Synthesis of Muraymycin D1 Having a Dual Mode of Action against Mycobacterium tuberculosis
- (2016) Katsuhiko Mitachi et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Development of an Intracellular Screen for New Compounds Able To Inhibit Mycobacterium tuberculosis Growth in Human Macrophages
- (2015) Flavia Sorrentino et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents
- (2015) Rangappa S. Keri et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Biosynthesis of a water-soluble lipid I analogue and a convenient assay for translocase I
- (2014) Shajila Siricilla et al. ANALYTICAL BIOCHEMISTRY
- Discovery of a capuramycin analog that kills nonreplicating Mycobacterium tuberculosis and its synergistic effects with translocase I inhibitors
- (2014) Shajila Siricilla et al. JOURNAL OF ANTIBIOTICS
- Characterization of the embB gene in Mycobacterium tuberculosis isolates from Barcelona and rapid detection of main mutations related to ethambutol resistance using a low-density DNA array
- (2013) R. Moure et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- A Dual Read-Out Assay to Evaluate the Potency of Compounds Active against Mycobacterium tuberculosis
- (2013) Juliane Ollinger et al. PLoS One
- TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS
- (2013) Lanfranco Fattorini et al. Mediterranean Journal of Hematology and Infectious Diseases
- Role of the Mmr Efflux Pump in Drug Resistance in Mycobacterium tuberculosis
- (2012) L. Rodrigues et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of Selective Menaquinone Biosynthesis Inhibitors against Mycobacterium tuberculosis
- (2012) Joy Debnath et al. JOURNAL OF MEDICINAL CHEMISTRY
- Divergent Effects of Mycobacterial Cell Wall Glycolipids on Maturation and Function of Human Monocyte-Derived Dendritic Cells
- (2012) Jolanta Mazurek et al. PLoS One
- Mutations in the rrs A1401G Gene and Phenotypic Resistance to Amikacin and Capreomycin in Mycobacterium tuberculosis
- (2011) Frederick A. Sirgel et al. Microbial Drug Resistance
- Emergence and Molecular Characterization of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates from the Delhi Region in India
- (2010) A. Khanna et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Activity of Drug Combinations against Dormant Mycobacterium tuberculosis
- (2010) P. Filippini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis
- (2010) J. E. M. de Steenwinkel et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Contribution of dfrA and inhA Mutations to the Detection of Isoniazid-Resistant Mycobacterium tuberculosis Isolates
- (2009) Y. M. Ho et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- MenA Is a Promising Drug Target for Developing Novel Lead Molecules to Combat Mycobacterium tuberculosis
- (2009) Michio Kurosu et al. Medicinal Chemistry
- Dormant forms of Mycobacterium smegmatis with distinct morphology
- (2009) A. M. Anuchin et al. MICROBIOLOGY-SGM
- Metronidazole Lacks Activity againstMycobacterium tuberculosisin an In Vivo Hypoxic Granuloma Model of Latency
- (2008) Lee G. Klinkenberg et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search